Cite
HARVARD Citation
Christie, J. et al. (2015). A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. Critical care medicine. 43 (9), p. . [Online].